Keywords
Atypical hemolytic uremic syndrome
COVID-19
microangiopathic anemia
hemolytic anemia
acute respiratory distress syndrome
COVID-19
microangiopathic anemia
hemolytic anemia
acute respiratory distress syndrome
Categories
How to Cite
1.
Atypical hemolytc uremic syndrome secondary to SARS – CoV – 2 infection. A case report. Rev Arg de Ter Int. [Internet]. 2022 Apr. 25 [cited 2025 Dec. 13];39. Available from: https://revista.sati.org.ar/index.php/MI/article/view/814
Abstract
Atypical hemolytic uremic syndrome (aHUS) is a rare entity in the intensive care unit, however, with a characteristic diagnostic triad and a specific treatment that can improve the morbidity and mortality associated with this syndrome.
Below we present the case of a 72-year-old male patient who was admitted to the intensive care unit with diagnosis of SARS-CoV-2 pneumonia, who developed aHUS secondary to this infection throughout his admission. Eculizumab could not be administered due to the sudden evolution towards multiorgan dysfunction syndrome and death.
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.